CA1275373C - Appareil et methode pour la perfusion rapide de liquides pour aider la circulation - Google Patents
Appareil et methode pour la perfusion rapide de liquides pour aider la circulationInfo
- Publication number
- CA1275373C CA1275373C CA000535062A CA535062A CA1275373C CA 1275373 C CA1275373 C CA 1275373C CA 000535062 A CA000535062 A CA 000535062A CA 535062 A CA535062 A CA 535062A CA 1275373 C CA1275373 C CA 1275373C
- Authority
- CA
- Canada
- Prior art keywords
- housing
- fluid
- blood
- infusion
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 130
- 238000001802 infusion Methods 0.000 title claims abstract description 111
- 230000003319 supportive effect Effects 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title abstract description 24
- 210000004369 blood Anatomy 0.000 claims abstract description 199
- 239000008280 blood Substances 0.000 claims abstract description 199
- 238000010792 warming Methods 0.000 claims abstract description 16
- 230000005779 cell damage Effects 0.000 claims abstract description 15
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 9
- 210000003462 vein Anatomy 0.000 claims abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 29
- 238000004891 communication Methods 0.000 claims description 29
- 230000006854 communication Effects 0.000 claims description 29
- 239000001301 oxygen Substances 0.000 claims description 29
- 229910052760 oxygen Inorganic materials 0.000 claims description 29
- 239000000523 sample Substances 0.000 claims description 16
- 230000004087 circulation Effects 0.000 claims description 14
- 239000007789 gas Substances 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 9
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- 238000005304 joining Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 238000006213 oxygenation reaction Methods 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 229940125691 blood product Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000002271 resection Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 239000010836 blood and blood product Substances 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000004023 fresh frozen plasma Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 206010015719 Exsanguination Diseases 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 201000004193 respiratory failure Diseases 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010000369 Accident Diseases 0.000 description 1
- 101100243025 Arabidopsis thaliana PCO2 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- -1 but not limited to Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007688 edging Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 238000004868 gas analysis Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229940021317 other blood product in atc Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000535062A CA1275373C (fr) | 1987-04-21 | 1987-04-21 | Appareil et methode pour la perfusion rapide de liquides pour aider la circulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000535062A CA1275373C (fr) | 1987-04-21 | 1987-04-21 | Appareil et methode pour la perfusion rapide de liquides pour aider la circulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1275373C true CA1275373C (fr) | 1990-10-23 |
Family
ID=4135460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000535062A Expired - Lifetime CA1275373C (fr) | 1987-04-21 | 1987-04-21 | Appareil et methode pour la perfusion rapide de liquides pour aider la circulation |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1275373C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112236080A (zh) * | 2018-06-11 | 2021-01-15 | 爱德华兹生命科学公司 | 用于血液采样-血压监测系统的管系统 |
-
1987
- 1987-04-21 CA CA000535062A patent/CA1275373C/fr not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112236080A (zh) * | 2018-06-11 | 2021-01-15 | 爱德华兹生命科学公司 | 用于血液采样-血压监测系统的管系统 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5383854A (en) | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method | |
| US4705508A (en) | Apparatus and method for rapid infusion of circulatory supportive fluids | |
| CA2245843C (fr) | Reservoir de recueil de sang autologue en circuit ferme | |
| JP4467187B2 (ja) | 手術システムのための支持デバイス | |
| US4747826A (en) | Rapid venous infusion system | |
| US4874359A (en) | Power infuser | |
| CA1042747A (fr) | Circulation extracorporelle | |
| EP3650057B1 (fr) | Systèmes et procédés de traitement du sang | |
| JPS62500006A (ja) | 完全携帯式、半自動機械式心肺機能代行装置およびその方法 | |
| DK161940B (da) | Dobbeltroer-kateter og apparatur til in-vivorensning af blod | |
| WO2016100512A1 (fr) | Dispositif d'assistance pulmonaire portable | |
| US5540653A (en) | Preassembled bypass circuit | |
| US20210379265A1 (en) | Method and system for controlled hyperthermia | |
| Darling et al. | Experimental use of an ultra-low prime neonatal cardiopulmonary bypass circuit utilizing vacuum-assisted venous drainage | |
| Berryessa et al. | Practical techniques Vacuum-assisted venous return in pediatric cardiopulmonary bypass | |
| CA1275373C (fr) | Appareil et methode pour la perfusion rapide de liquides pour aider la circulation | |
| US4857052A (en) | Intravenous system for delivering a beneficial agent | |
| GB2210797A (en) | Blood oxygenator apparatus | |
| ES3015545T3 (en) | Microplegia delivery system | |
| US11219551B1 (en) | Method and system for controlled hyperthermia | |
| US11191883B1 (en) | Method and system for controlled hyperthermia | |
| JPH0464706B2 (fr) | ||
| Gorney et al. | A modification of the sarns conducer heat exchanger as a low prime pediatric cardioplegia system | |
| Hill et al. | Can vacuum assisted venous drainage be achieved using a roller pump in an emergency? A pilot study using neonatal circuitry | |
| Hiroura et al. | Clinical experience of a vacuum-assisted nonroller extra-corporeal circulation system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |